A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis
Clinical trial NCT04679870 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04679870
- Sponsor
- Galecto Biotech AB
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-09
- Primary completion
- 2023-12-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.